104 related articles for article (PubMed ID: 28167236)
1. Rapamycin and the inhibition of the secretory phenotype.
Wang R; Sunchu B; Perez VI
Exp Gerontol; 2017 Aug; 94():89-92. PubMed ID: 28167236
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging.
Blagosklonny MV
Aging (Albany NY); 2012 Mar; 4(3):159-65. PubMed ID: 22394614
[TBL] [Abstract][Full Text] [Related]
3. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation.
Laberge RM; Sun Y; Orjalo AV; Patil CK; Freund A; Zhou L; Curran SC; Davalos AR; Wilson-Edell KA; Liu S; Limbad C; Demaria M; Li P; Hubbard GB; Ikeno Y; Javors M; Desprez PY; Benz CC; Kapahi P; Nelson PS; Campisi J
Nat Cell Biol; 2015 Aug; 17(8):1049-61. PubMed ID: 26147250
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mammalian target of rapamycin signaling by CCI-779 (temsirolimus) induces growth inhibition and cell cycle arrest in Cashmere goat fetal fibroblasts (Capra hircus).
Wang Z; Liu T; Chen Y; Zhang X; Liu M; Fu H; Liu D
DNA Cell Biol; 2012 Jun; 31(6):1095-9. PubMed ID: 22320865
[TBL] [Abstract][Full Text] [Related]
5. mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype.
Herranz N; Gallage S; Mellone M; Wuestefeld T; Klotz S; Hanley CJ; Raguz S; Acosta JC; Innes AJ; Banito A; Georgilis A; Montoya A; Wolter K; Dharmalingam G; Faull P; Carroll T; Martínez-Barbera JP; Cutillas P; Reisinger F; Heikenwalder M; Miller RA; Withers D; Zender L; Thomas GJ; Gil J
Nat Cell Biol; 2015 Sep; 17(9):1205-17. PubMed ID: 26280535
[TBL] [Abstract][Full Text] [Related]
6. Dietary rapamycin supplementation reverses age-related vascular dysfunction and oxidative stress, while modulating nutrient-sensing, cell cycle, and senescence pathways.
Lesniewski LA; Seals DR; Walker AE; Henson GD; Blimline MW; Trott DW; Bosshardt GC; LaRocca TJ; Lawson BR; Zigler MC; Donato AJ
Aging Cell; 2017 Feb; 16(1):17-26. PubMed ID: 27660040
[TBL] [Abstract][Full Text] [Related]
7. mTOR and its link to the picture of Dorian Gray - re-activation of mTOR promotes aging.
Wesierska-Gadek J
Aging (Albany NY); 2010 Dec; 2(12):892-3. PubMed ID: 21149896
[No Abstract] [Full Text] [Related]
8. Forever young, slim and fit: rapamycin to the rescue.
Darzynkiewicz Z
Cell Cycle; 2009 Jun; 8(12):1820-1. PubMed ID: 19471126
[No Abstract] [Full Text] [Related]
9. Glucocorticoids suppress selected components of the senescence-associated secretory phenotype.
Laberge RM; Zhou L; Sarantos MR; Rodier F; Freund A; de Keizer PL; Liu S; Demaria M; Cong YS; Kapahi P; Desprez PY; Hughes RE; Campisi J
Aging Cell; 2012 Aug; 11(4):569-78. PubMed ID: 22404905
[TBL] [Abstract][Full Text] [Related]
10. mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis.
Iglesias-Bartolome R; Patel V; Cotrim A; Leelahavanichkul K; Molinolo AA; Mitchell JB; Gutkind JS
Cell Stem Cell; 2012 Sep; 11(3):401-14. PubMed ID: 22958932
[TBL] [Abstract][Full Text] [Related]
11. A non-canonical role of ELN protects from cellular senescence by limiting iron-dependent regulation of gene expression.
Czarnecka-Herok J; Zhu K; Flaman JM; Goehrig D; Vernier M; Makulyte G; Lamboux A; Dragic H; Rhinn M; Médard JJ; Faury G; Bertolino P; Balter V; Debret R; Adnot S; Martin N; Bernard D
Redox Biol; 2024 Jul; 73():103204. PubMed ID: 38810421
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin, anti-aging, and avoiding the fate of Tithonus.
Richardson A
J Clin Invest; 2013 Aug; 123(8):3204-6. PubMed ID: 24063054
[TBL] [Abstract][Full Text] [Related]
13. Relief with rapamycin: mTOR inhibition protects against radiation-induced mucositis.
Finkel T
Cell Stem Cell; 2012 Sep; 11(3):287-8. PubMed ID: 22958927
[TBL] [Abstract][Full Text] [Related]
14. Too big not to fail: emerging evidence for size-induced senescence.
Manohar S; Neurohr GE
FEBS J; 2024 Jun; 291(11):2291-2305. PubMed ID: 37986656
[TBL] [Abstract][Full Text] [Related]
15. Rapid and simple detection of gero-suppressive agents.
Darzynkiewicz Z
Oncotarget; 2015 Sep; 6(27):23050-1. PubMed ID: 26375365
[No Abstract] [Full Text] [Related]
16. Running m(o)TOR with the brakes on leads to catastrophe at mitosis.
Darzynkiewicz Z
Cell Cycle; 2012 Dec; 11(24):4494. PubMed ID: 23222065
[No Abstract] [Full Text] [Related]
17. Author Correction: mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype.
Herranz N; Gallage S; Mellone M; Wuestefeld T; Klotz S; Hanley CJ; Raguz S; Acosta JC; Innes AJ; Banito A; Georgilis A; Montoya A; Wolter K; Dharmalingam G; Faull P; Carroll T; Martínez-Barbera JP; Cutillas P; Reisinger F; Heikenwalder M; Miller RA; Withers D; Zender L; Thomas GJ; Gil J
Nat Cell Biol; 2024 Jun; 26(6):1019. PubMed ID: 38778130
[No Abstract] [Full Text] [Related]
18. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism.
Wang R; Yu Z; Sunchu B; Shoaf J; Dang I; Zhao S; Caples K; Bradley L; Beaver LM; Ho E; Löhr CV; Perez VI
Aging Cell; 2017 Jun; 16(3):564-574. PubMed ID: 28371119
[TBL] [Abstract][Full Text] [Related]
19. mTORC2 facilitates endothelial cell senescence by suppressing Nrf2 expression via the Akt/GSK-3β/C/EBPα signaling pathway.
Yang HW; Hong HL; Luo WW; Dai CM; Chen XY; Wang LP; Li Q; Li ZQ; Liu PQ; Li ZM
Acta Pharmacol Sin; 2018 Dec; 39(12):1837-1846. PubMed ID: 29991711
[TBL] [Abstract][Full Text] [Related]
20. mTOR pathway activation drives lung cell senescence and emphysema.
Houssaini A; Breau M; Kebe K; Abid S; Marcos E; Lipskaia L; Rideau D; Parpaleix A; Huang J; Amsellem V; Vienney N; Validire P; Maitre B; Attwe A; Lukas C; Vindrieux D; Boczkowski J; Derumeaux G; Pende M; Bernard D; Meiners S; Adnot S
JCI Insight; 2018 Feb; 3(3):. PubMed ID: 29415880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
